Digital Engagement With The Patient
As emerging technologies are integrated into society, the pathway to connect to the patient becomes much shorter. Managing patient symptoms and proactively engage patients for therapeutic options opens up the door for even more discovery and dialogue. See how we create these tools to enable your organization to change what it means for developing ‘patient care’.
Disease & Cancer Genetics
Research and Development
Virtual trial Design / Real-World Evidence
Post Market Surveillance
Digital Research and Life Sciences
Our mission is to ensure that therapeutics and vaccines developed within the life science industry factor in every patient ethnicity and demographics to bolster product efficacy, health equity, and effective patient outcomes.
At Rubix LS, we deliver the data, research, and case management solutions to help life science companies target and address these problems from the onset to ensure that we shorten the gap between delivering highly effective and all-inclusive, product innovations while ensuring inclusivity of all patient populations, equally receive the lifesaving benefits needed in today’s world.
Our focus is simple: Patient Innovation First. Always.
Also supporting the federal markets.
As the world shifts to defend against new emerging health threats, government agencies are grappling with new ways to overcome those challenges. Agile convergence of digital and scientific innovation becomes a crucial vehicle to deliver outcomes-based approaches to achieve mission objectives.
We’re not just innovators, we’re also creating the entrepreneurial structure into agencies that will increase strength and expansion into programs that will catapult science and technology forward.
Latest News & Articles
Rubix LS is creating device to help aid the CDC in target spread of the Wuhan Coronavirus within the U.S.
In the wake of the current COVID-19 crisis plaguing the world, many life science and health technology organizations are mobilizing ways to assist in containing and managing patient symptoms as well as racing toward a vaccine. While the world is approximately 12-18...
July 16, 2019, Lawrence, MA - Today, Rubix LS is happy to announce that is reached SBA 8a status. Started in 1942, the SBA 8a program was developed to address vast disparities of economic opportunities, through business encouragement for minorities and key groups that...